Advisory Board Reports
Edition 17 of the Code of Conduct requires that all Medicines Australia members must report details of the aggregate fees paid by them to participate in Advisory Boards.
“Advisory Board” is not defined under the Code. It is generally understood to refer to a meeting of healthcare professionals with specific expertise contracted to meet at regular intervals to provide advice on a Company’s Product or group of products. An Advisory Board for a given Product may be conducted for a number of years and the membership of the Board may vary over time. The meetings are commonly held at external venues.
Advisory Board reports are to be submitted to Medicines Australia every six months. The reporting periods are April – September; and October – March. Reports are to be submitted to Medicines Australia within one month of the end of the reporting period. All Member Company reports are to be published by Medicines Australia within three months of the end of the reporting period.
Company Reports Summary
|11 January 2013 – 31 March 2013|
|Number of reports||22|
|Number of Advisory Boards||49|
|Number of attendees||376|
|Total Honoraria/Sitting Fees||$603,701.25|
|Average cost of hospitality per head||$485.86|
|Total cost of Advisory Boards||$951,863.07|
|Average cost of Advisory Board per head||$2,531.55|
NOTE: As Edition 17 became effective in the middle of a reporting period, the initial reports only include those Advisory Boards held on or after 11 January 2013.
Page updated: June 2013